Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia

Ashutosh Lal, Lasandra Patterson, Alisa Goldrich, Anne Marsh, Ashutosh Lal, Lasandra Patterson, Alisa Goldrich, Anne Marsh

Abstract

Carbon monoxide (CO) production from heme catabolism is increased with hemolysis. A portable end-tidal CO (ETCO) monitor was used to analyze breath samples in 16 children with sickle cell anemia (SCA, 5-14 years). Median (range) ETCO for SCA was 4.35 ppm (1.8-9.7) versus 0.80 ppm (0.2-2.3) for controls (P < 0.001). ETCOc >2.1 ppm provided sensitivity and specificity of 93.8% (69.8-99.8%) for detecting SCA. ETCO correlated with reticulocytosis (P = 0.015) and bilirubin (P = 0.009), and was 32% lower in children receiving hydroxyurea (P = 0.09). Point-of-care ETCO analysis may prove useful for non-invasive monitoring of hemolysis and as a screening test for SCA.

Keywords: hemoglobinopathies; red blood cell disorders; sickle cell anemia.

Conflict of interest statement

Conflict of Interest: None

© 2015 Wiley Periodicals, Inc.

Figures

Figure 1
Figure 1
(A) End-tidal carbon monoxide concentration in children with sickle cell anemia (SCA) and healthy age-matched controls (n=16 for both groups). Whiskers extend from 10-90th percentile (+: mean). (B) Receiver-operator characteristic curve (solid line) for ETCOc in children with or without a diagnosis of SCA. A threshold ETCOc value of 2.1 ppm provided a sensitivity and specificity of 93.8% to differentiate between the two groups. (Dotted line: line of identity).
Figure 2
Figure 2
Association of end-tidal carbon monoxide concentration (ETCOc) with absolute reticulocyte count (Figure 2A, n=15), and serum bilirubin concentration (Figure 2B, n=12).

Source: PubMed

3
Prenumerera